Fusion Rate



Recovery Time



Incision Size


With over 14,000 procedures performed in the US, and 80+ medical studies establishing the safety, efficacy and biomechanics of AxiaLIF+®there is ample reason to explore AxiaLIF+® as a standard fusion procedure with an alternate approach.

“We strive to support surgeons who share the belief that AxiaLIF+® provides positive patient outcomes from a unique access point and smaller incision than other approaches.”

John Miller

Vice President of Sales, TranS1

“At TranS1, we believe in the promise of AxiaLIF+® and its minimally invasive approach to fusion at the L5-S1 disc space.”

Jeff Schell

CEO, TranS1